By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AnaptysBio, Inc. 

10835 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-362-6295 Fax: 858-362-6296




Company News
AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial 7/6/2016 6:11:26 AM
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer 4/18/2016 7:43:30 AM
AnaptysBio Announces First-In-Human Dosing Of Anti-IL-33 Antibody 3/10/2016 6:18:56 AM
AnaptysBio Announces Appointment Of James A. Schoeneck To Board Of Directors 11/19/2015 7:02:09 AM
San Diego's AnaptysBio Preps for $86 Million IPO 9/10/2015 6:09:36 AM
San Diego's AnaptysBio Rakes in $40 Million 7/15/2015 6:41:03 AM
AnaptysBio Appoints Robert E. Hoffman As Chief Financial Officer 7/13/2015 6:30:22 AM
AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 4/16/2015 6:29:05 AM
AnaptysBio Recruits Ex-Pfizer (PFE) R&D Star to Lead Translational Biology 4/7/2015 5:32:28 AM
Tesaro, Inc. (TSRO) And AnaptysBio, Inc. Expand Immuno-Oncology Collaboration To Include Novel Bispecific Antibody Candidate 12/2/2014 11:51:12 AM